Clinical Trials in Los Angeles

Showing 10481-10500 of 14,465 trials

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

NCT01236768

The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.

Contraception

Agile Therapeutics407 participantsStarted Oct 2010

Mobile, Alabama, United States • Green Valley, Arizona, United States • Tucson, Arizona, United States +18 more locations

COMPLETEDPhase 2< 1 mile

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

NCT00309179

This study proposes to determine the safety of the administration of E7820 plus cetuximab and explore the MTD of the combination in a Phase Ib study. In addition, the efficacy of this combination will be explored in patients with colorectal cancer in the Phase II proof of concept phase of the study.

Advanced Colorectal Cancer

Eisai Inc.41 participantsStarted Sep 2007

Los Angeles, California, United States • Miami, Florida, United States • Edmonton, Alberta, Canada

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Find Trials by Condition in Los Angeles

Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

GSK2251052 in Complicated Urinary Tract Infection

Evaluating BMD in Participants ≥50 Years Old Switching From EVG/COBI/FTC/TAF or EVG/COBI/FTC/TDF to ABC/DTG/3TC

Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects

A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis